Results of Treatment Approaches in Myeloid Neoplasms According to TP53 Allelic Status (Multi-hit vs Monoallelic), a Real World Analysis

被引：0
|
作者：
Sola, Maria [1 ,2 ]
Beas, Francisco [1 ,3 ]
Palomo, Laura [4 ,5 ]
Tormo, Mar [6 ]
Riera, Ana [6 ]
Diaz Varela, Nicolas [7 ]
Bernal, Teresa [7 ]
Garcia, Sara [8 ]
Fernandez, Concepcion [8 ,9 ]
Garcia-Gisbert, Nieves [8 ,9 ]
Lopez Cadenas, Felix [8 ]
Tazon, Barbara [4 ,5 ]
Blanco, Adoracion [4 ,5 ]
Garrido Paniagua, Sara [4 ,5 ]
Perez Gonzalez, Ana [4 ,5 ]
Jerez, Andres [4 ,5 ]
Montoro, Julia [2 ,4 ]
Salamero, Olga [4 ,5 ]
Valcarcel, David [4 ,5 ]
机构：
[1] Vall dHebron Inst Oncol VHIO, Expt Hematol Unit, Barcelona, Spain
[2] Univ Autonoma Barcelona UAB, Dept Hematol, Vall dHebron Univ Hosp, Barcelona, Spain
[3] Vall dHebron Univ Hosp, Dept Hematol, Barcelona, Spain
[4] Vall dHebron Inst Oncol VHIO, Barcelona, Spain
[5] Vall dHebron Univ Hosp, Dept Hematol, Barcelona, Spain
[6] Hosp Clin Univ Valencia, Inst Invest Sanitaria INCLIVA, Valencia, Spain
[7] Hosp Univ Cent Asturias, Inst Univ IUOPA, Inst Invest Principado Asturias ISPA, Oviedo, Spain
[8] Hosp del Mar, Dept Hematol, Barcelona, Spain
[9] IMIM Hosp del Mar, Barcelona, Spain
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187101
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 15 条
  • [1] TP53 Allelic Status in TP53 Mutated Therapy-Related Myeloid Neoplasms is Inconsequential
    Zak, Taylor
    Sukhanova, Madina
    Gao, Juehua
    Behdad, Amir
    Chen, Yi-Hua
    Chen, Qing
    Tariq, Hamza
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1520 - S1522
  • [2] Impact of Multi-Hit vs Single-Hit TP53 Mutations in Chronic Lymphocytic Leukemia
    Hwang, Steven
    Wang, Yucai
    Rabe, Kari
    Williams-Watley, Marquise
    Hampel, Paul
    Kenderian, Saad
    Muchtar, Eli
    Koehler, Amber
    Behnken, Amy
    Kay, Neil
    Parikh, Sameer
    He, Rong
    Ding, Wei
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S320 - S320
  • [3] MDS with Mono-Allelic TP53 Mutation and Complex Karyotype Shows Similar Prognosis to MDS with Bi-Allelic/Multi-Hit TP53 Lesions
    Yabe, Mariko
    Weinberg, Olga
    Siddon, Alexa
    Ouseph, Madhu
    Hasserjian, Robert
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1505 - S1507
  • [4] Therapy-related myeloid neoplasms with single-hit TP53 mutations share the clinical, molecular, and survival characteristics of their multi-hit counterparts
    Zak, Taylor
    Sukhanova, Madina
    Gao, Juehua
    Fu, Lucy
    Chen, Yi-Hua
    Chen, Qing Ching
    Behdad, Amir
    Tariq, Hamza
    LEUKEMIA & LYMPHOMA, 2024, 65 (11) : 1691 - 1697
  • [5] Prognostic impact of 'multi-hit' versus 'single-hit' TP53 alteration in patients with acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases
    Badar, Talha
    Nanaa, Ahmad
    Atallah, Ehab
    Shallis, Rory M.
    Craver, Emily C.
    Li, Zhuo
    Goldberg, Aaron D.
    Saliba, Antoine N.
    Patel, Anand
    Bewersdorf, Jan P.
    Duvall, Adam
    Burkart, Madelyn
    Bradshaw, Danielle
    Abaza, Yasmin
    Stahl, Maximilian
    Palmisiano, Neil
    Murthy, Guru Subramanian Guru
    Zeidan, Amer M.
    Kota, Vamsi
    Patnaik, Mrinal M.
    Litzow, Mark R.
    HAEMATOLOGICA, 2024, 109 (11) : 3533 - 3542
  • [6] Multi- Hit TP53 Mutations in Myeloid Neoplasms: Prognostic Impact of Morphologic Subtype Designation and Variant Allele Frequency
    Abdelmagid, Maymona
    Reichard, Kaaren K.
    Karrar, Omer
    He, Rong
    Greipp, Patricia
    Ketterling, Rhett
    Shah, Mithun V.
    Hiwase, Devendra
    Orazi, Attilio
    Arber, Daniel A.
    Gangat, Naseema
    Tefferi, Ayalew
    BLOOD, 2023, 142
  • [7] Prognostic implications of mono-hit and multi-hit TP53 alterations in patients with acute myeloid leukemia and higher risk myelodysplastic syndromes treated with azacitidine-based therapy
    Zeidan, Amer M.
    Bewersdorf, Jan Philipp
    Hasle, Vanessa
    Shallis, Rory M.
    Thompson, Ethan
    de Menezes, Daniel Lopes
    Rose, Shelonidta
    Boss, Isaac
    Halene, Stephanie
    Haferlach, Torsten
    Fox, Brian
    LEUKEMIA, 2023, 37 (01) : 240 - 243
  • [8] Prognostic implications of mono-hit and multi-hit TP53 alterations in patients with acute myeloid leukemia and higher risk myelodysplastic syndromes treated with azacitidine-based therapy
    Amer M. Zeidan
    Jan Philipp Bewersdorf
    Vanessa Hasle
    Rory M. Shallis
    Ethan Thompson
    Daniel Lopes de Menezes
    Shelonidta Rose
    Isaac Boss
    Stephanie Halene
    Torsten Haferlach
    Brian Fox
    Leukemia, 2023, 37 : 240 - 243
  • [9] Real World Data on Decitabine Treatment in 296 Patients with Acute Myeloid Leukemia: Outcome and Impact of TP53 Mutations
    Rollig, Christoph
    Middeke, Jan Moritz
    Stasik, Sebastian
    Zebisch, Armin
    Sill, Heinz
    Kramer, Michael
    Scholl, Sebastian
    Hochhaus, Andreas
    Jost, Edgar
    Brummendorf, Tim H.
    Naumann, Ralph
    Steffen, Bjorn
    Serve, Hubert
    Altmann, Heidi
    Kunzmann, Volker
    Einsele, Hermann
    Parmentier, Stefani Barbara
    Schaich, Markus
    Burchert, Andreas
    Neubauer, Andreas
    Heits, Frank
    Berdel, Wolfgang E.
    Sockel, Katja
    Stoelzel, Friedrich
    Platzbecker, Uwe
    Ehninger, Gerhard
    Bornhauser, Martin
    Schetelig, Johannes
    Thiede, Christian
    BLOOD, 2017, 130
  • [10] Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotype
    Thomas, Johanna
    Rehman, Usama-Ur
    Bresser, Helena
    Grishina, Olga
    Pfeifer, Dietmar
    Sollier, Etienne
    Doehner, Konstanze
    Plass, Christoph
    Becker, Heiko
    Schmoor, Claudia
    de Wit, Maike
    Luebbert, Michael
    CLINICAL EPIGENETICS, 2024, 16 (01)
12